呼吸用吸入器の世界市場分析

【英語タイトル】Respiratory Inhaler Devices Market: Metered Dose Inhaler Most Lucrative Product Type Segment During the Forecast Period: Global Industry Analysis 2012 - 2016 and Opportunity Assessment 2017 - 2027

Future Market Insightsが出版した調査資料(FUMI712023)・商品コード:FUMI712023
・発行会社(調査会社):Future Market Insights
・発行日:2017年10月25日
・ページ数:247
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール
・調査対象地域:グローバル
・産業分野:Healthcare, Pharmaceuticals and Medical devices
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥545,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥817,500見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
※本調査レポートでは、呼吸用吸入器の世界市場について調査・分析し、以下の構成でお届けいたします。
・呼吸用吸入器の世界市場概観
・呼吸用吸入器の世界市場規模
・呼吸用吸入器の世界市場予測
・呼吸用吸入器の世界市場:地域別市場分析
・呼吸用吸入器のアメリカ市場規模
・呼吸用吸入器のヨーロッパ市場規模
・呼吸用吸入器のアジア市場規模
・呼吸用吸入器の世界市場:セグメント別市場分析
製品種類別
-乾燥粉末
-定量噴霧器
-ネブライザー

技術別
-手動式
-デジタル式

疾患別
-喘息
-慢性閉塞性肺疾患(COPD)
-肺動脈高血圧症
-その他・呼吸用吸入器の世界市場:競争状況
・呼吸用吸入器の世界市場:市場動向
・呼吸用吸入器の世界市場:関連企業分析
【レポートの概要】

Future Market Insights offers 10-year forecast on the global respiratory inhaler devices market between 2017 and 2027. This study covers the market dynamics and trends in major countries that are expected to influence the current market scenario and future status of the global respiratory inhaler devices market over the forecast period. The global respiratory inhaler device market report provides analysis and insights on respiratory inhalers. Primary factors fuelling demand for respiratory inhaler device market are increasing prevalence of asthma, COPD and other respiratory diseases coupled with rising awareness that has triggered the usage of respiratory inhaler devices worldwide. This is expected to bolster the growth of the respiratory inhaler devices market over the next five to six years. Increasing demand for respiratory inhaler devices for controlling asthma and other respiratory disease, especially among children and elderly population, is expected to drive growth of respiratory inhaler devices market during the forecast period. Companies are focusing on regions and sections where prevalence of asthma, and chronic lung diseases are increasing such as Asia Pacific and MEA.

To understand and assess various opportunities in this market, the report is categorically split into four sections, namely market analysis by product type, technology, disease indication and region. The report analyses the global respiratory inhaler device market in terms of value (US$ Mn).

The report starts with an overview of the global respiratory inhaler device. In the same section, FMI covers the global respiratory inhaler device market performance in terms of value. This section also includes FMI’s analysis of key trends, drivers, and restraints from supply and demand perspectives. The report also cover the opportunities in the global respiratory inhaler device market.

The next section of the report analyses the market on the basis of respiratory inhaler device market segment and presents the forecast in terms of value for all years till 2027. The market has been segmented as follows:

By Product Type

Dry Powder Inhaler
Metered Dose Inhaler
Nebulizer
Ultrasonic Nebulizer
Compressed Air Nebulizer
Mesh Nebulizer
By Technology

Manually Operated Inhaler Devices
Digitally Operated Inhaler Devices
By Disease Indication

Asthma
COPD
Pulmonary Arterial Hypertension
Others Respiratory Disease
The next section analyses the market on the basis of regions in terms of value for the forecast period. Regions covered in the report are as follows

By Region

North America
U.S.
Canada
Latin America
Argentina
Brazil
Mexico
Rest of LA
Western Europe
Germany
France
U.K
Italy
Spain
Nordic
BENELUX
Rest of WE
Eastern Europe
Poland
Russia
Rest of EE
Asia Pacific Excluding Japan
China
India
Australia &b New Zealand
ASEAN
Rest of APEJ
Japan
Middle East & Africa
GCC countries
South Africa
North Africa
Rest of MEA
To reach market size, the report considers market value of the global respiratory inhaler device across the above-mentioned regions. The market estimation presented in the report evaluates the total revenue generated in the global respiratory inhaler device market over the forecast period. When developing the market forecast, the starting point involves sizing up the current market, which forms the basis of the forecast. For this, FMI conducted interviews with several subject matter experts in the respiratory inhaler device domain across the globe. Given the scenario of the market, FMI triangulated the outcome based on analysis from the supply side, demand side and also the dynamics of the market. In this report, quantification of data has been conducted along with qualitative analysis.

We have also taken into consideration the year-on-year growth of the global respiratory inhaler device market, based on regional growth analysis, to understand the predictability of the market and to identify the key opportunities. Another key feature of this report is the analysis of the global respiratory inhaler device market, by region, which is further segmented on the basis of countries and revenue forecast in terms of absolute dollar (US$) opportunity. Regional trends have been introspected, identified and applied while carrying out the forecasting of the market. Additionally, the absolute dollar opportunity provided in the report is critical in assessing the level of opportunity that a provider can look to achieve from a sales perspective in the global respiratory inhaler device market.

【レポートの目次】

Table Of Content

1. Executive Summary

1.1. Overview

1.2. FMI Analysis and Recommendations

1.3. Wheel of Fortune

2. Market Introduction

2.1. Market Taxonomy

2.2. Market Definition

3. Respiratory Inhaler Devices Market View Point

3.1. Macro-Economic Factors

3.2. Opportunity Analysis

3.3. Regulatory Scenario

3.4. Respiratory Inhaler Devices Market Dynamics

3.4.1. Drivers

3.4.2. Restraints

3.4.3. Trends

4. North America Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

4.1. Introduction

4.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016

4.2.1. U.S.

4.2.2. Canada

4.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027

4.3.1. U.S.

4.3.2. Canada

4.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

4.4.1. Dry Powder Inhaler

4.4.2. Metered Dose Inhaler

4.4.3. Nebulizer

4.4.3.1. Compressed Air Nebulizers

4.4.3.2. Ultrasonic Nebulizers

4.4.3.3. Mesh Nebulizers

4.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

4.5.1. Dry Powder Inhaler

4.5.2. Metered Dose Inhaler

4.5.3. Nebulizer

4.5.3.1. Compressed Air Nebulizers

4.5.3.2. Ultrasonic Nebulizers

4.5.3.3. Mesh Nebulizers

4.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

4.6.1. Manually Operated Inhaler Devices

4.6.2. Digitally Operated Inhaler Devices

4.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

4.7.1. Manually Operated Inhaler Devices

4.7.2. Digitally Operated Inhaler Devices

4.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

4.8.1. Asthma

4.8.2. COPD

4.8.3. Pulmonary Arterial Hypertension

4.8.4. Others Respiratory Disease

4.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

4.9.1. Asthma

4.9.2. COPD

4.9.3. Pulmonary Arterial Hypertension

4.9.4. Others Respiratory Disease

4.10. Drivers and Restraints: Impact Analysis

4.11. Market Attractiveness Analysis

4.11.1. By Country

4.11.2. By Product

4.11.3. By Technology

4.11.4. Disease Indication

5. Latin America Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

5.1. Introduction

5.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016

5.2.1. Brazil

5.2.2. Mexico

5.2.3. Rest of Latin America

5.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027

5.3.1. Brazil

5.3.2. Mexico

5.3.3. Rest of Latin America

5.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

5.4.1. Dry Powder Inhaler

5.4.2. Metered Dose Inhaler

5.4.3. Nebulizer

5.4.3.1. Compressed Air Nebulizers

5.4.3.2. Ultrasonic Nebulizers

5.4.3.3. Mesh Nebulizers

5.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

5.5.1. Dry Powder Inhaler

5.5.2. Metered Dose Inhaler

5.5.3. Nebulizer

5.5.3.1. Compressed Air Nebulizers

5.5.3.2. Ultrasonic Nebulizers

5.5.3.3. Mesh Nebulizers

5.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

5.6.1. Manually Operated Inhaler Devices

5.6.2. Digitally Operated Inhaler Devices

5.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

5.7.1. Manually Operated Inhaler Devices

5.7.2. Digitally Operated Inhaler Devices

5.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

5.8.1. Asthma

5.8.2. COPD

5.8.3. Pulmonary Arterial Hypertension

5.8.4. Others Respiratory Disease

5.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

5.9.1. Asthma

5.9.2. COPD

5.9.3. Pulmonary Arterial Hypertension

5.9.4. Others Respiratory Disease

5.10. Drivers and Restraints: Impact Analysis

5.11. Market Attractiveness Analysis

5.11.1. By Country

5.11.2. By Product

5.11.3. By Technology

5.11.4. Disease Indication

6. Western Europe Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

6.1. Introduction

6.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016

6.2.1. Germany

6.2.2. Italy

6.2.3. France

6.2.4. Spain

6.2.5. U.K.

6.2.6. BENELUX

6.2.7. Nordic

6.2.8. Rest of Western Europe

6.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027

6.3.1. Germany

6.3.2. Italy

6.3.3. France

6.3.4. Spain

6.3.5. U.K.

6.3.6. BENELUX

6.3.7. Nordic

6.3.8. Rest of Western Europe

6.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

6.4.1. Dry Powder Inhaler

6.4.2. Metered Dose Inhaler

6.4.3. Nebulizer

6.4.3.1. Compressed Air Nebulizers

6.4.3.2. Ultrasonic Nebulizers

6.4.3.3. Mesh Nebulizers

6.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

6.5.1. Dry Powder Inhaler

6.5.2. Metered Dose Inhaler

6.5.3. Nebulizer

6.5.3.1. Compressed Air Nebulizers

6.5.3.2. Ultrasonic Nebulizers

6.5.3.3. Mesh Nebulizers

6.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

6.6.1. Manually Operated Inhaler Devices

6.6.2. Digitally Operated Inhaler Devices

6.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

6.7.1. Manually Operated Inhaler Devices

6.7.2. Digitally Operated Inhaler Devices

6.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

6.8.1. Asthma

6.8.2. COPD

6.8.3. Pulmonary Arterial Hypertension

6.8.4. Others Respiratory Disease

6.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

6.9.1. Asthma

6.9.2. COPD

6.9.3. Pulmonary Arterial Hypertension

6.9.4. Others Respiratory Disease

6.10. Drivers and Restraints: Impact Analysis

6.11. Market Attractiveness Analysis

6.11.1. By Country

6.11.2. By Product

6.11.3. By Technology

6.11.4. Disease Indication

7. Eastern Europe Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

7.1. Introduction

7.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016

7.2.1. Russia

7.2.2. Poland

7.2.3. Rest of Eastern Europe

7.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027

7.3.1. Russia

7.3.2. Poland

7.3.3. Rest of Eastern Europe

7.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

7.4.1. Dry Powder Inhaler

7.4.2. Metered Dose Inhaler

7.4.3. Nebulizer

7.4.3.1. Compressed Air Nebulizers

7.4.3.2. Ultrasonic Nebulizers

7.4.3.3. Mesh Nebulizers

7.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

7.5.1. Dry Powder Inhaler

7.5.2. Metered Dose Inhaler

7.5.3. Nebulizer

7.5.3.1. Compressed Air Nebulizers

7.5.3.2. Ultrasonic Nebulizers

7.5.3.3. Mesh Nebulizers

7.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

7.6.1. Manually Operated Inhaler Devices

7.6.2. Digitally Operated Inhaler Devices

7.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

7.7.1. Manually Operated Inhaler Devices

7.7.2. Digitally Operated Inhaler Devices

7.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

7.8.1. Asthma

7.8.2. COPD

7.8.3. Pulmonary Arterial Hypertension

7.8.4. Others Respiratory Disease

7.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

7.9.1. Asthma

7.9.2. COPD

7.9.3. Pulmonary Arterial Hypertension

7.9.4. Others Respiratory Disease

7.10. Drivers and Restraints: Impact Analysis

7.11. Market Attractiveness Analysis

7.11.1. By Country

7.11.2. By Product

7.11.3. By Technology

7.11.4. Disease Indication

8. Asia Pacific excluding Japan Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

8.1. Introduction

8.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016

8.2.1. China

8.2.2. India

8.2.3. ASEAN

8.2.4. Australia and New Zealand

8.2.5. Rest of APEJ

8.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027

8.3.1. China

8.3.2. India

8.3.3. ASEAN

8.3.4. Australia and New Zealand

8.3.5. Rest of APEJ

8.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

8.4.1. Dry Powder Inhaler

8.4.2. Metered Dose Inhaler

8.4.3. Nebulizer

8.4.3.1. Compressed Air Nebulizers

8.4.3.2. Ultrasonic Nebulizers

8.4.3.3. Mesh Nebulizers

8.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

8.5.1. Dry Powder Inhaler

8.5.2. Metered Dose Inhaler

8.5.3. Nebulizer

8.5.3.1. Compressed Air Nebulizers

8.5.3.2. Ultrasonic Nebulizers

8.5.3.3. Mesh Nebulizers

8.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

8.6.1. Manually Operated Inhaler Devices

8.6.2. Digitally Operated Inhaler Devices

8.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

8.7.1. Manually Operated Inhaler Devices

8.7.2. Digitally Operated Inhaler Devices

8.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

8.8.1. Asthma

8.8.2. COPD

8.8.3. Pulmonary Arterial Hypertension

8.8.4. Others Respiratory Disease

8.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

8.9.1. Asthma

8.9.2. COPD

8.9.3. Pulmonary Arterial Hypertension

8.9.4. Others Respiratory Disease

8.10. Drivers and Restraints: Impact Analysis

8.11. Market Attractiveness Analysis

8.11.1. By Country

8.11.2. By Product

8.11.3. By Technology

8.11.4. Disease Indication

9. Japan Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

9.1. Introduction

9.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

9.2.1. Dry Powder Inhaler

9.2.2. Metered Dose Inhaler

9.2.3. Nebulizer

9.2.3.1. Compressed Air Nebulizers

9.2.3.2. Ultrasonic Nebulizers

9.2.3.3. Mesh Nebulizers

9.3. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

9.3.1. Dry Powder Inhaler

9.3.2. Metered Dose Inhaler

9.3.3. Nebulizer

9.3.3.1. Compressed Air Nebulizers

9.3.3.2. Ultrasonic Nebulizers

9.3.3.3. Mesh Nebulizers

9.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

9.4.1. Manually Operated Inhaler Devices

9.4.2. Digitally Operated Inhaler Devices

9.5. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

9.5.1. Manually Operated Inhaler Devices

9.5.2. Digitally Operated Inhaler Devices

9.6. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

9.6.1. Asthma

9.6.2. COPD

9.6.3. Pulmonary Arterial Hypertension

9.6.4. Others Respiratory Disease

9.7. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

9.7.1. Asthma

9.7.2. COPD

9.7.3. Pulmonary Arterial Hypertension

9.7.4. Others Respiratory Disease

9.8. Drivers and Restraints: Impact Analysis

9.9. Market Attractiveness Analysis

9.9.1. By Product

9.9.2. By Technology

9.9.3. Disease Indication

10. Middle East & Africa Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

10.1. Introduction

10.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Country, 2012–2016

10.2.1. GCC Countries

10.2.2. Northern Africa

10.2.3. South Africa

10.2.4. Rest of MEA

10.3. Market Size (US$ Mn) and Volume Forecast By Country, 2017–2027

10.3.1. GCC Countries

10.3.2. Northern Africa

10.3.3. South Africa

10.3.4. Rest of MEA

10.4. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

10.4.1. Dry Powder Inhaler

10.4.2. Metered Dose Inhaler

10.4.3. Nebulizer

10.4.3.1. Compressed Air Nebulizers

10.4.3.2. Ultrasonic Nebulizers

10.4.3.3. Mesh Nebulizers

10.5. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

10.5.1. Dry Powder Inhaler

10.5.2. Metered Dose Inhaler

10.5.3. Nebulizer

10.5.3.1. Compressed Air Nebulizers

10.5.3.2. Ultrasonic Nebulizers

10.5.3.3. Mesh Nebulizers

10.6. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

10.6.1. Manually Operated Inhaler Devices

10.6.2. Digitally Operated Inhaler Devices

10.7. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

10.7.1. Manually Operated Inhaler Devices

10.7.2. Digitally Operated Inhaler Devices

10.8. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

10.8.1. Asthma

10.8.2. COPD

10.8.3. Pulmonary Arterial Hypertension

10.8.4. Others Respiratory Disease

10.9. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

10.9.1. Asthma

10.9.2. COPD

10.9.3. Pulmonary Arterial Hypertension

10.9.4. Others Respiratory Disease

10.10. Drivers and Restraints: Impact Analysis

10.11. Market Attractiveness Analysis

10.11.1. By Country

10.11.2. By Product

10.11.3. By Technology

10.11.4. Disease Indication

11. Forecast Factors: Relevance and Impact

12. Forecast Assumptions

13. Competition Landscape

13.1. Competition Dashboard

13.2. Company Profiles (Details – Overview, Financials, Strategy, SWOT, Recent Developments)

13.2.1. AstraZeneca

13.2.2. Beximco Pharmaceuticals Ltd.

13.2.3. Boehringer Ingelheim GmbH

13.2.4. Cipla Ltd.

13.2.5. GlaxoSmithKline plc

13.2.6. Koninklijke Philips N.V.

13.2.7. Merck & Co., Inc.

13.2.8. OMRON Healthcare Europe B.V.

13.2.9. PARI Medical Holding

13.2.10. Teva Pharmaceutical Industries Ltd

14. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, By Region

14.1. Introduction/Key Findings

14.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Region, 2012–2016

14.2.1. North America

14.2.2. Latin America

14.2.3. Western Europe

14.2.4. Eastern Europe

14.2.5. Asia Pacific excluding Japan

14.2.6. Japan

14.2.7. Middle East & Africa

14.3. Market Size (US$ Mn) and Volume Forecast By Region, 2017–2027

14.3.1. North America

14.3.2. Latin America

14.3.3. Western Europe

14.3.4. Eastern Europe

14.3.5. Asia Pacific excluding Japan

14.3.6. Japan

14.3.7. Middle East & Africa

14.4. Market Attractiveness Analysis By Region

15. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, By Product

15.1. Introduction/Key Findings

15.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Product, 2012–2016

15.2.1. Dry Powder Inhaler

15.2.2. Metered Dose Inhaler

15.2.3. Nebulizer

15.2.3.1. Compressed Air Nebulizers

15.2.3.2. Ultrasonic Nebulizers

15.2.3.3. Mesh Nebulizers

15.3. Market Size (US$ Mn) and Volume Forecast By Product, 2017–2027

15.3.1. Dry Powder Inhaler

15.3.2. Metered Dose Inhaler

15.3.3. Nebulizer

15.3.3.1. Compressed Air Nebulizers

15.3.3.2. Ultrasonic Nebulizers

15.3.3.3. Mesh Nebulizers

15.4. Market Attractiveness Analysis By Product

16. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, Technology

16.1. Introduction/Key Findings

16.2. Historical Market Size (US$ Mn) and Volume Trend Analysis By Technology, 2012–2016

16.2.1. Manually Operated Inhaler Devices

16.2.2. Digitally Operated Inhaler Devices

16.3. Market Size (US$ Mn) and Volume Forecast By Technology, 2017–2027

16.3.1. Manually Operated Inhaler Devices

16.3.2. Digitally Operated Inhaler Devices

16.4. Market Attractiveness Analysis Disease Indication

17. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027, Disease Indication

17.1. Introduction/Key Findings

17.2. Historical Market Size (US$ Mn) and Volume Trend Analysis Disease Indication, 2012–2016

17.2.1. Asthma

17.2.2. COPD

17.2.3. Pulmonary Arterial Hypertension

17.2.4. Others Respiratory Disease

17.3. Market Size (US$ Mn) and Volume Forecast Disease Indication, 2017–2027

17.3.1. Asthma

17.3.2. COPD

17.3.3. Pulmonary Arterial Hypertension

17.3.4. Others Respiratory Disease

17.4. Market Attractiveness Analysis Disease Indication

18. Global Respiratory Inhaler Devices Market Analysis 2012–2016 and Forecast 2017–2027

18.1. Market Size and Y-o-Y Growth

18.2. Absolute $ Opportunity

List of Tables

Table 01: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 02: North America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 03: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 04: North America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 05: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 06: North America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 07: North America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 08: North America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 09: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 10: Latin America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 11: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 12: Latin America Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 13: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 14: Latin America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 15: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 16: Latin America Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 17: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 18: Western Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 19: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 20: Western Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 21: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 22: Western Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 23: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 24: Western Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 25: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 26: Eastern Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 27: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 28: Eastern Europe Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 29: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 30: Eastern Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 31: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 32: Eastern Europe Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 33: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 34: APEJ Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 35: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 36: APEJ Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 37: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 38: APEJ Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 39: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 40: APEJ Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 41: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 42: Japan Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 43: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 44: Japan Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 45: Japan Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 46: Japan Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 47: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 48: MEA Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Country

Table 49: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 50: MEA Respiratory Inhaler Devices Market Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Product Type

Table 51: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 52: MEA Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Technology

Table 53: MEA Respiratory Inhaler Devices Market Size (US$ Mn) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 54: MEA Respiratory Inhaler Devices Volume (1000`) Analysis 2012–2016 and Forecast 2017–2027, By Disease Indication

Table 55: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Region, 2012–2017

Table 56: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Region, 2012–2017

Table 57: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Product Type, 2012–2017

Table 58: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Product Type, 2012–2017

Table 59: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Technology, 2012–2017

Table 60: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Technology, 2012–2017

Table 61: Global Respiratory Inhaler Devices Market Size (US$ Mn) Forecast by Disease Indication, 2012–2017

Table 62: Global Respiratory Inhaler Devices Market Volume (1000`) Forecast by Disease Indication, 2012–2017

List of Figures

Figure 01: North America Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 02: North America Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 03: North America Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 04: North America Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 05: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 06: U.S. Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 07: Canada Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 08: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 09: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 10: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 11: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 12: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 13: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 14: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 15: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 16: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 17: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 18: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 19: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 20: North America Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027

Figure 21: Latin America Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 22: Latin America Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 23: Latin America Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 24: Latin America Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 25: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 26: Argentina Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 27: Mexico Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 28: Brazil Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 29: Rest of Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 30: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 31: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 32: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 33: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 34: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 35: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 36: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 37: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 38: Latin America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 39: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 40: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 41: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 42: Latin America Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027

Figure 43: Western Europe Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 44: Western Europe Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 45: Western Europe Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 46: Western Europe Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 47: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 48: Germany Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 49: France Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 50: U.K Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 51: Italy Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 52: Spain Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 53: BENELUX Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 54: NORDIC Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 55: Rest of Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 56: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 57: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 58: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 59: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 60: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 61: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 62: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 63: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 64: Western Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 65: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 66: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 67: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 68: Western Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027

Figure 69: Eastern Europe Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 70: Eastern Europe Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 71: Eastern Europe Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 72: Eastern Europe Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 73: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 74: Russia Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 75: Rest of Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 76: Poland Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 77: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 78: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 79: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 80: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 81: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 82: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 83: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 84: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 85: Eastern Europe Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 86: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 87: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 88: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 89: Eastern Europe Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027

Figure 90: APEJ Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 91: APEJ Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 92: APEJ Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 93: APEJ Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 94: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 95: China Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 96: Australia & New Zealand Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 97: India Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 98: ASEAN Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 99: Rest of APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 100: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 101: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 102: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 103: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 104: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 105: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 106: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 107: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 108: APEJ Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 109: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 110: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 111: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 112: APEJ Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027

Figure 113: Japan Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 114: Japan Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 115: Japan Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 116: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 117: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 118: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 119: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 120: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 121: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 122: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 123: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 124: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 125: Japan Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 126: Japan Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 127: Japan Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 128: Japan Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 129: MEA Respiratory Inhaler Devices Market Value Share By Product (2017)

Figure 130: MEA Respiratory Inhaler Devices Market Value Share By Technology (2017)

Figure 131: MEA Respiratory Inhaler Devices Market Value Share By Country (2017)

Figure 132: MEA Respiratory Inhaler Devices Market Historical Market Size (US$ Mn) Analysis, 2012–2016

Figure 133: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Figure 134: GCC Countries Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 135: North Africa Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 136: South Africa Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 137: Rest of MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 138: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 139: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 140: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 141: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Manually Operated Inhaler Devices, 2012–2027

Figure 142: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Digitally Operated Inhaler Devices, 2012–2027

Figure 143: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 144: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 145: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 146: MEA Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 147: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Product Type, 2017–2027

Figure 148: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Technology, 2017–2027

Figure 149: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Disease Indication, 2017–2027

Figure 150: MEA Respiratory Inhaler Devices Market Attractiveness Analysis By Country, 2017–2027

Figure 151: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Region, 2017–2027

Figure 152: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Dry Powder Inhaler, 2012–2027

Figure 153: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Nebulizer, 2012–2027

Figure 154: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Metered Dose Inhaler, 2012–2027

Figure 155: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Product Type, 2017–2027

Figure 156: Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 157: Rest of Global Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%), 2012–2027

Figure 158: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Technology, 2017–2027

Figure 159: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Asthma, 2012–2027

Figure 160: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Pulmonary Arterial Hypertension, 2012–2027

Figure 161: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By COPD, 2012–2027

Figure 162: North America Respiratory Inhaler Devices Market Size (US$ Mn) & Y-o-Y Growth (%) By Others, 2012–2027

Figure 163: Global Respiratory Inhaler Devices Market Attractiveness Analysis by Disease Indication, 2017–2027

Figure 164: Global Respiratory Inhaler Devices Market Value Analysis and Forecast, 2016–2027 (US$ Mn)

Figure 165: Global Respiratory Inhaler Devices Market Absolute $ Opportunity (US$ Mn), 2016–2027

★調査レポート[呼吸用吸入器の世界市場分析] (コード:FUMI712023)販売に関する免責事項を必ずご確認ください。
★調査レポート[呼吸用吸入器の世界市場分析]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆